| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 01/28/2014 | CA2535265C Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 01/23/2014 | WO2014014835A2 Crystalline forms of a prolyl hydroxylase inhibitor |
| 01/23/2014 | WO2014014834A1 Process for making isoquinoline compounds |
| 01/23/2014 | WO2014014270A1 Isoquinoline-5-carboxamide derivative having inhibitory activity for protein kinase |
| 01/23/2014 | WO2014012934A1 Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof |
| 01/23/2014 | US20140024676 Crystalline forms of a prolyl hydroxylase inhibitor |
| 01/23/2014 | US20140024675 Crystalline forms of a prolyl hydroxylase inhibitor |
| 01/22/2014 | EP2687507A1 Nitrogen-containing condensed heterocyclic compound |
| 01/22/2014 | EP2686302A1 Sulfonamide compounds having trpm8 antagonistic activity |
| 01/22/2014 | CN103524412A Isoquinolone derivative and synthetic method thereof |
| 01/21/2014 | US8633182 Indanyloxyphenylcyclopropanecarboxylic acids |
| 01/15/2014 | EP2684468A1 Salty taste enhancer |
| 01/15/2014 | CN103508940A 6, 6-disubstituted-6-H-benzo[cd]pyrene derivatives and intermediates, and preparation methods and applications of derivatives and intermediates |
| 01/15/2014 | CN102203067B Hedgehog pathway modulators |
| 01/14/2014 | CA2623213C Piperazine derivatives as antimalarial agents |
| 01/09/2014 | WO2014005968A1 Novel adamantyl derivatives as cannabinoid receptor 2 agonists |
| 01/09/2014 | WO2014005601A1 A process for the preparation of solifenacin or a salt thereof |
| 01/09/2014 | CA2876443A1 Novel adamantyl derivatives as cannabinoid receptor 2 agonists |
| 01/07/2014 | US8624032 Compound libraries made through phosphine-catalyzed annulation/Tebbe/Diels-Alder reactions |
| 01/07/2014 | US8623889 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof |
| 01/07/2014 | US8623867 Cyclic amine BACE-1 inhibitors having a benzamide substituent |
| 01/03/2014 | WO2014000694A1 Phendioxin heterocycle derivative |
| 01/03/2014 | WO2013000651A8 Fluorinated arylalkylaminocarboxamide derivatives |
| 01/02/2014 | US20140005393 Sulfonamide compounds having trpm8 antagonistic activity |
| 01/02/2014 | US20140005382 Nitrogen-containing condensed heterocyclic compound |
| 01/01/2014 | CN103483255A Fluorinated isoquinoline compounds and preparation method thereof |
| 01/01/2014 | CN103483251A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 12/31/2013 | US8618296 Arylethynyl derivatives |
| 12/31/2013 | US8618295 Preparation of luminescent iridium complexes and precursors thereof |
| 12/31/2013 | US8618129 Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as KCNQ2/3 modulators |
| 12/31/2013 | CA2666246C Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 12/31/2013 | CA2643394C Ligands, their preparation and uses thereof in asymmetric reactions |
| 12/31/2013 | CA2552565C Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 12/31/2013 | CA2544678C Modulators of cellular adhesion |
| 12/27/2013 | WO2013189800A1 Cisatracurium and beta-cyclodextrin derivative compositions |
| 12/26/2013 | US20130345313 Method for the treatment or prevention of lower urinary tract symptoms |
| 12/25/2013 | EP2675791A1 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a) |
| 12/25/2013 | EP2429295B1 Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof |
| 12/25/2013 | EP2152670B1 Bridged six-membered ring compounds |
| 12/25/2013 | CN103476757A Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A) |
| 12/25/2013 | CN103476756A 3-ureidoisoquinolin-8-yl derivatives |
| 12/24/2013 | US8614227 Salt and solvates of a tetrahydroisoquinoline derivative |
| 12/24/2013 | CA2605510C Inhibitors of microsomal triglyceride transfer protein and apo-b secretion |
| 12/19/2013 | WO2013185353A1 Compound as wnt signaling inhibitor, composition, and use thereof |
| 12/19/2013 | US20130338187 Novel 1-(1-OXO-1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL)Urea Derivatives As N-FORMYL Peptide Receptor Like-1 (FPRL-1) Receptor Modulators |
| 12/19/2013 | CA2875372A1 Compound as wnt signaling inhibitor, composition, and use thereof |
| 12/18/2013 | EP2673263A1 Novel 1-(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 12/18/2013 | CN103459369A 胍化合物 Guanidine compound |
| 12/18/2013 | CN103450079A Tetrahydroisoquinoline hydroxyl derivate, preparation method and medical application thereof |
| 12/18/2013 | CN103449945A Visible light catalyzed cross-coupling hydrogen desorption method |
| 12/17/2013 | US8609691 Cyclohexylamin isoquinolone derivatives |
| 12/17/2013 | CA2749114C Heteroatom-containing cyclic compound |
| 12/17/2013 | CA2733533C Hedgehog pathway modulators |
| 12/11/2013 | EP2671869A1 Tetrahydroisoquinoline derivative |
| 12/11/2013 | EP2670734A1 Novel ether linked compounds and improved treatments for cardiac and cardiovascular disease |
| 12/11/2013 | CN103443080A Sulfonamide compounds having TRPM8 antagonistic activity |
| 12/11/2013 | CN103442712A Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 12/11/2013 | CN103435635A Preparation method of magnesium chloride (2,2,6,6-tetramethyl piperidine) lithium salt |
| 12/11/2013 | CN103435595A Acetylenic heteroaryl compounds |
| 12/11/2013 | CN103435546A Method for preparing isoquinoline compounds |
| 12/11/2013 | CN103435545A Tetrahydroisoquinoline quaternary ammonium salt derivatives as well as preparation method and analgesia application thereof |
| 12/11/2013 | CN102442965B PAR-1 (protease-activated receptor-1) antagonists for treating thrombotic diseases, as well as preparation and application thereof |
| 12/11/2013 | CN101888999B Pyridylmethyl-sulfonamide compounds |
| 12/10/2013 | US8604200 Diaza-spiro-{4,4}-nonane derivatives as neurokinin (NK1) antagonists |
| 12/05/2013 | WO2013178816A1 Heterocycles capable of modulating t-cell responses, and methods of using same |
| 12/05/2013 | US20130324718 Processes and reagents for making diaryliodonium salts |
| 12/05/2013 | CA2874938A1 Heterocycles capable of modulating t-cell responses, and methods of using same |
| 12/04/2013 | EP2667870A1 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 12/04/2013 | CN203319892U Novel carbon-11 multifunctional automatic synthesis module |
| 12/03/2013 | US8598364 Oligomer-protease inhibitor conjugates |
| 12/03/2013 | CA2599411C Enzyme inhibitors |
| 11/28/2013 | WO2013174736A1 N-[3-(2-carboxyethyl)phenyl]piperidin-1-ylacetamide derivatives and use thereof as activators of soluble guanylate cyclase |
| 11/28/2013 | US20130317010 Tetrahydroisoquinoline derivative |
| 11/28/2013 | DE102012208530A1 Substituierte Piperidinoacetamide und ihre Verwendung Substituted Piperidinoacetamide and their use |
| 11/27/2013 | EP2665725A1 Bicyclic inhibitors of alk |
| 11/27/2013 | CN102757370B Derivatives of p-aminobenzoic acid and applications thereof |
| 11/26/2013 | US8592608 Triple reuptake inhibitors and methods of their use |
| 11/26/2013 | US8592451 Reversible nondepolarizing neuromuscular blockade agents and methods for their use |
| 11/26/2013 | US8592416 Isoquinolin-1 (2H)-one derivatives as PARP-1 inhibitors |
| 11/21/2013 | US20130310565 Novel nitrogen-containing heteroaryl compounds and methods of use thereof |
| 11/21/2013 | US20130310559 Isoprenyl compounds and methods thereof |
| 11/21/2013 | US20130310555 Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions |
| 11/20/2013 | EP2389226B1 Bridged and fused heterocyclic antidiabetic compounds |
| 11/20/2013 | CN103402949A A new palladium catalyst, method for its preparation and its use |
| 11/20/2013 | CN103396361A 3, 4-dihydroisoquinoline antitumor compounds as well as preparation method and application thereof |
| 11/19/2013 | US8586570 Sox-based kinase sensor |
| 11/14/2013 | US20130303522 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 11/14/2013 | US20130303506 Amino-derivatives as novel inhibitors of histone deacetylase |
| 11/12/2013 | US8580817 1-(1-OXO-1,2,3,4-tetrahydroisoquinolin-7-YL)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators |
| 11/12/2013 | CA2621836C Isoquinolines as igf-1r inhibitors |
| 11/12/2013 | CA2565184C Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof |
| 11/12/2013 | CA2537093C Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 11/06/2013 | CN103384669A Bicyclic inhibitors of ALK |
| 11/05/2013 | US8575193 N-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds |
| 10/31/2013 | US20130289280 Novel pharmaceutical forms, and methods of making and using the same |
| 10/31/2013 | US20130289027 Isoquinoline Compounds And Methods For Treating HIV |
| 10/30/2013 | EP2657227A1 Novel substituted isoquinoline derivative |
| 10/30/2013 | CN103373971A Urea compounds serving as protein kinase inhibitors |
| 10/30/2013 | CN103373959A Preparation method of cis-benzyl isoquinoline compound and application thereof |
| 10/30/2013 | CN101578266B Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives |